Adamus T, Kortylewski M. The revival of CpG oligonucleotide-based cancer immunotherapies. Contemporary Oncology/Współczesna Onkologia. 2018:56-60. doi:10.5114/wo.2018.73887.
APA
Adamus, T., & Kortylewski, M. (2018). The revival of CpG oligonucleotide-based cancer immunotherapies. Contemporary Oncology/Współczesna Onkologia, 56-60. https://doi.org/10.5114/wo.2018.73887
Chicago
Adamus, Tomasz, and Marcin Kortylewski. 2018. "The revival of CpG oligonucleotide-based cancer immunotherapies". Contemporary Oncology/Współczesna Onkologia: 56-60. doi:10.5114/wo.2018.73887.
Harvard
Adamus, T., and Kortylewski, M. (2018). The revival of CpG oligonucleotide-based cancer immunotherapies. Contemporary Oncology/Współczesna Onkologia, pp.56-60. https://doi.org/10.5114/wo.2018.73887
MLA
Adamus, Tomasz et al. "The revival of CpG oligonucleotide-based cancer immunotherapies." Contemporary Oncology/Współczesna Onkologia, 2018, pp. 56-60. doi:10.5114/wo.2018.73887.
Vancouver
Adamus T, Kortylewski M. The revival of CpG oligonucleotide-based cancer immunotherapies. Contemporary Oncology/Współczesna Onkologia. 2018:56-60. doi:10.5114/wo.2018.73887.
